Bristol Myers Short and Long Term Debt Total History
| BMY Stock | USD 58.71 -0.31 -0.53% |
Short and Long Term Debt Total | First Reported 1987-12-31 | Previous Quarter 51 B | Current Value 47.1 B | Quarterly Volatility 16.2 B |
Macro event markers
Latest Bristol Myers Short and Long Term Debt Total Growth Pattern
| Short and Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Short and Long Term Debt Total Trend Statistics
The coefficient of variation for Bristol Myers' Short and Long Term Debt Total stands at 82.4%, reflecting wide dispersion driven primarily by directional growth rather than instability across 15 periods. With an R-squared of 0.77, the data suggests a strong linear fit indicating consistent directional movement.| Arithmetic Mean | 25,487,173,529 | |
| Geometric Mean | 15,090,643,776 | |
| Coefficient Of Variation | 82.42 | |
| Mean Deviation | 20,108,889,619 | |
| Median | 8,340,000,000 | |
| Standard Deviation | 21,005,469,707 | |
| Sample Variance | 441229757.6T | |
| Range | 51B | |
| R-Value | 0.88 | |
| Mean Square Error | 108771931T | |
| R-Squared | 0.77 | |
| Slope | 3,647,486,765 | |
| Total Sum of Squares | 7059676121.6T |
Bristol Myers Short and Long Term Debt Total History
Bristol Myers' Short and Long Term Debt Total is tracked from 2012 through 2026, spanning 15 reported values, moving from 7.4 B to 49.5 B.| 2026 | 49.5 B | ||
| 2025 | 47.1 B | ||
| 2024 | 51.2 B | ||
| 2023 | 41.5 B | ||
| 2022 | 40.7 B | ||
| 2021 | 45.6 B | ||
| 2020 | 51.7 B | ||
| 2019 | 47.5 B | ||
| 2018 | 7.3 B | ||
| 2017 | 8 B | ||
| 2016 | 6.7 B | ||
| 2015 | 6.7 B | ||
| 2014 | 7.8 B | ||
| 2013 | 8.3 B | ||
| 2012 | 7.4 B |
Correlation of Short and Long Term Debt Total With Other Accounts
Linear correlations between Short and Long Term Debt Total and other accounts within Bristol Myers' reporting history are shown below. Strong correlations may reflect underlying operational relationships or scaling effects across related metrics.Click cells to compare fundamentals
Related Fundamentals
| Last Reported | End Of Year Estimate | ||
| Cash And Short Term Investments | 10.7 B | 6.4 B | |
| Short Term Debt | 2.5 B | 2.6 B | |
| Short Term Investments | 464 M | 440.8 M | |
| Short and Long Term Debt | 2.3 B | 2.7 B | |
| Short Term Coverage Ratios | 6.26 | 11.03 |
Methodology, Assumptions & Data Sources
A longitudinal view of Bristol Myers's Short and Long Term Debt Total is provided for trend analysis. Mean-reversion tendencies in this metric suggest cyclical operating drivers rather than a permanent shift in trajectory. For Bristol Myers in the Pharmaceuticals sector, Short and Long Term Debt Total captures the scale of obligations used to fund operations and growth.
Bristol Myers Squibb inputs come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Analyst inputs may be included when coverage is available. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.
Editorial review and methodology oversight provided by: Vlad Skutelnik, Macroaxis Contributor